Surgery Partners is trading at $14.87, down 5.89%, as broader risk-off trading pressures equities.

  • No new company announcement dated September 23, 2026, appears on Surgery Partners’ investor-relations news page; its latest release is dated September 17.
  • Crude oil is rising, Treasury yields are approaching 4.99%, and major indexes are declining.
  • The decline follows the prior session’s 15.67% surge after the Idaho Falls divestiture, with profit-taking potentially amplifying macro pressure.